Wealthquest’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$350K Buy
6,075
+204
+3% +$11.7K 0.02% 124
2026
Q1
$356K Buy
5,871
+111
+2% +$6.47K 0.03% 104
2025
Q4
$311K Buy
+5,760
New +$277K 0.02% 106
2025
Q2
Sell
-4,669
Closed -$285K 138
2025
Q1
$285K Sell
4,669
-276
-6% -$16.1K 0.02% 102
2024
Q4
$280K Buy
4,945
+135
+3% +$7.54K 0.02% 103
2024
Q3
$254K Sell
4,810
-1,300
-21% -$61K 0.02% 107
2024
Q2
$254K Sell
6,110
-20
-0.3% -$895 0.03% 110
2024
Q1
$332K Hold
6,130
0.04% 97
2023
Q4
$315K Sell
6,130
-92
-1% -$4.83K 0.03% 102
2023
Q3
$361K Buy
+6,222
New +$381K 0.04% 89
2023
Q2
Sell
-3,726
Closed -$258K 122
2023
Q1
$258K Sell
3,726
-233
-6% -$16.4K 0.03% 104
2022
Q4
$285K Hold
3,959
0.04% 101
2022
Q3
$281K Sell
3,959
-106
-3% -$7.69K 0.04% 97
2022
Q2
$313K Sell
4,065
-1
-0% -$76 0.05% 94
2022
Q1
$253K Hold
4,066
0.04% 124
2021
Q4
$253K Buy
+4,066
New +$239K 0.04% 124
2021
Q3
Sell
-3,512
Closed -$234K 137
2021
Q2
$234K Buy
3,512
+46
+1% +$3K 0.04% 127
2021
Q1
$218K Sell
3,466
-56
-2% -$3.48K 0.04% 132
2020
Q4
$218K Buy
3,522
+56
+2% +$3.44K 0.05% 121
2020
Q3
$208K Sell
3,466
-189
-5% -$11.4K 0.05% 106
2020
Q2
$203K Buy
+3,655
New +$219K 0.05% 105
2019
Q4
$323K Buy
5,045
+432
+9% +$24.7K 0.09% 100
2019
Q3
$233K Buy
+4,613
New +$217K 0.08% 118
2019
Q2
Sell
-4,642
Closed -$221K 128
2019
Q1
$221K Sell
4,642
-237
-5% -$11.8K 0.08% 122
2018
Q4
$253K Buy
+4,879
New +$262K 0.1% 105

Other funds holding BMY

Wealthquest's BMY Position: Q2 2026 in Review

Wealthquest increased its Bristol-Myers Squibb (BMY) stake by 3.5% in Q2 2026, buying an estimated $11.7K and bringing the position to 6,075 shares worth $350K. The position accounts for 0.02% of the portfolio, ranked #124.

Wealthquest first reported a position in BMY in Q4 2018 and has held it in 25 quarters since. The position peaked at $361K in Q3 2023. 848 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Wealthquest held 6,075 shares of Bristol-Myers Squibb worth $350K as of Q2 2026.
  • Wealthquest bought 204 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.7K.
  • Bristol-Myers Squibb made up 0.02% of Wealthquest's portfolio in Q2 2026, its #124 holding.
  • Wealthquest first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 25 quarters since.
  • Wealthquest's Bristol-Myers Squibb position peaked at $361K in Q3 2023.
  • 848 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Wealthquest's 13F filing for Q2 2026, filed 23 Jul 2026.